Glenmark Pharmaceuticals (GLENMARK.NS) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
0250M500M750M1B1B2B2B2BQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
038M75M112M150M188M225M262M300MQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

EBITDA

EBITDA
025M50M75M100M125M150M175M200MQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

EPS

EPSEPS Diluted
000001111Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Revenue Variation (%)

Revenue Variation
-50-31-12625446281100Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Income Variation (%)

Gross Profit VariationOperating Income Variation
062125188250312375438500Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Revenue YoY Variation (%)

Revenue YoY Variation
-30-150153045607590Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
0255075100125150175200Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Price-to-Earning Ratio

P/E Ratio
03757501K2K2K2K3K3KQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
03875112150188225262300Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Per Share Metrics

Operating IncomeTotal Other Income Expenses NetNet Income
038M75M112M150M188M225M262M300MQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
050100150200250300350400Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
088M175M262M350M438M525M612M700MQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Cash Flow to Debt Ratio

Cash At End Of Period
050M100M150M200M250M300M350M400MQ2 2026
🏦 Balance Sheet
📈 Key Metrics